MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617069585 A) filed by Glaxosmithkline Intellectual Property on June 03, 2026, for Baff Specific Antibodies.
Inventors include Ahmed, Farheen; Orecchia, Martin; and Ovecka, Milan Number.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention relates to anti-BLyS antigen binding proteins such as an anti-BLyS antibody which is capable of antagonizing BLyS. The invention also relates to nucleic acid sequences which encode the antigen binding protein as well as the use the antigen binding protein in therapy, for example, in diseases in which B cells play a pathogenic role, such as, for example, in autoimmune diseases, chronic inflammatory diseases and/or cancer.
Disclaimer: Curated by HT Syndication.
